ID
22012
Beschrijving
Therapy of Metastatic Breast Cancer With Paclitaxel and Liposomal Doxorubicin; ODM derived from: https://clinicaltrials.gov/show/NCT00691912
Link
https://clinicaltrials.gov/show/NCT00691912
Trefwoorden
Versies (1)
- 14-05-17 14-05-17 -
Geüploaded op
14 mei 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Metastatic Breast Cancer NCT00691912
Eligibility Metastatic Breast Cancer NCT00691912
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
high dose therapy with stem cell support
Datatype
boolean
Alias
- UMLS CUI [1]
- C1512429
Beschrijving
cumulative anthracycline dose, epirubicin, doxorubicin, mitoxantrone
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C2986497
- UMLS CUI [1,2]
- C0282564
- UMLS CUI [1,3]
- C0014582
- UMLS CUI [1,4]
- C0013089
- UMLS CUI [1,5]
- C0026259
Beschrijving
concomitant hormone, chemo-, radiotherapy
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1707479
- UMLS CUI [1,2]
- C0279025
- UMLS CUI [1,3]
- C0392920
- UMLS CUI [1,4]
- C1522449
Beschrijving
her2 neu
Datatype
boolean
Alias
- UMLS CUI [1]
- C1512413
Beschrijving
pregnancy, breast feeding
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0032961
- UMLS CUI [1,2]
- C0006147
Similar models
Eligibility Metastatic Breast Cancer NCT00691912
- StudyEvent: Eligibility
C0079399 (UMLS CUI [1,2])
C0001779 (UMLS CUI [1,3])
C0282564 (UMLS CUI [1,2])
C0014582 (UMLS CUI [1,3])
C0013089 (UMLS CUI [1,4])
C0026259 (UMLS CUI [1,5])
C0279025 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,3])
C1522449 (UMLS CUI [1,4])
C0006147 (UMLS CUI [1,2])